Xenotransplantation and Hepatitis e virus

Xenotransplantation

Volumn 22, Issue 3, 2015, Pages 167-173

  Denner, Joachim ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

hepatitis E virus; porcine endogenous retroviruses; virus safety of xenotransplantation

Indexed keywords

HEPATITIS E VACCINE;

DATA ANALYSIS; DRUG RESPONSE; GENOTYPE; HEALTH PROGRAM; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; INFECTION RISK; NONHUMAN; PIG FARMING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; REVIEW; RISK ASSESSMENT; RISK FACTOR; TRANSGENIC PIG; VIRUS STRAIN; VIRUS TRANSMISSION; XENOTRANSPLANTATION; ANIMAL; ENDOGENOUS RETROVIRUS; FEMALE; GENETICS; ISOLATION AND PURIFICATION; PIG; PREGNANCY; RISK; SWINE DISEASE; TRANSMISSION; VIROLOGY; XENOGRAFT; ZOONOSIS;

ANIMALS; ENDOGENOUS RETROVIRUSES; FEMALE; HEPATITIS E VIRUS; HUMANS; PREGNANCY; RISK; SWINE; SWINE DISEASES; TRANSPLANTATION, HETEROLOGOUS; ZOONOSES;

EID: 84930759076     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/xen.12156     Document Type: Review

References (80)

1. Meng XJ,. Hepatitis E virus: animal reservoirs and zoonotic risk. Vet Microbiol 2010; 140: 256-265.
2. Meng XJ,. Recent advances in Hepatitis E virus. J Viral Hep 2010; 17: 153-161.
3. Scobie L, Dalton HR,. Hepatitis E: source and route of infection, clinical manifestations and new developments. J Virol Hep 2013; 20: 1-11.
4. Meng XJ,. Swine hepatitis E virus: cross-species infection and risk in xenotransplantation. Curr Top Microbiol Immunol 2003; 278: 185-216.
5. Schlauder GG, Mushahwar IK,. Genetic heterogeneity of hepatitis E virus. J Med Virol 2001; 65: 282-292.
6. Lu L, Li C, Hagedorn CH,. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006; 16: 5-36.
7. Lu YH, Qian HZ, Qin X, Jiang QW, Zheng YJ,. Subtypes of genotype 3 hepatitis E virus in pigs. Vet J 2013; 197: 509-511.
8. Johne R, Dremsek P, Reetz J, et al., Hepeviridae: an expanding family of vertebrate viruses. Infect Genet Evol 2014; 27: 212-229.
9. Matsuda H, Okada K, Takahashi K, Mishiro S,. Severe hepatitis E virus infection after ingestion of uncooked liver from a wild boar. J Infect 2003; 188: 944.
10. Yazaki Y, Mizuo H, Takahashi M, et al., Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J Gen Virol 2003; 84: 2351-2357.
11. Meng XJ, Wiseman B, Elvinger F, et al., Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 2002; 40: 117-122.
12. Feagins AR, Opriessnig T, Guenette DK, Halbur PG, Meng XJ,. Detection and characterization of infectious Hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J Gen Virol 2007; 88: 912-917.
13. Bouwknegt M, Lodder-Verschoor F, van der Poel WH, Rutjes SA, de Roda Husman AM,. Hepatitis E virus RNA in commercial porcine livers in The Netherlands. J Food Prot 2007; 70: 2889-2895.
14. Colson P, Borentai P, Queyriaux B, et al., Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010; 202: 825-834.
15. Grodzki M, Schaeffer J, Piquet JC, et al., Bioaccumulation efficiency, tissue distribution, and environmental occurrence of hepatitis E virus in bivalve shellfish from France. Appl Environ Microbiol 2014; 80: 4269-4276.
16. Crossan C, Baker PJ, Craft J, et al., Hepatitis E virus genotype 3 in shellfish. United Kingdom. Emerg Infect Dis 2012; 18: 2085-2087.
17. Kokkinos P, Kozyra I, Lazic S, et al., Harmonised investigation of the occurrence of human enteric viruses in the leafy green vegetable supply chain in three European countries. Food Environ Virol 2012; 4: 179-191.
18. Baylis SA, Gartner T, Nick S, Ovemyr J, Blumel J,. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang 2012; 103: 89-90.
19. Beale MA, Tettmar K, Szypulska R, Tedder RS, Ijaz S,. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? Vox Sang 2011; 100: 340-342.
20. Boxall E, Herborn A, Kochethu G, et al., Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Trans Med 2006; 16: 79-83.
21. Gerolami R, Moal V, Colson P,. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. New Engl J Med 2008; 358: 859-860.
22. Gerolami R, Moal V, Picard C, Colson P,. Hepatitis E: virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 2009; 50: 622-704.
23. Kamar N, Mansuy JM, Cointault O, et al., Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant 2008; 8: 1744-1748.
24. Kamar N, Selves J, Mansuy JM, et al., Hepatitis E virus and chronic hepatitis in organ-transplant recipients. New Engl J Med 2008; 358: 811-817.
25. Okamoto H,. Genetic variability and evolution of hepatitis E virus. Virus Res 2007; 127: 216-628.
26. Pelosi E, Clarke I,. Hepatitis E: a complex and global disease. Emerg Health Threats J 2008; 1: e8.
27. Geng Y, Zhao C, Fan J, et al., Genotype analysis of hepatitis E virus from sporadic hepatitis E cases in northern China. Infect Genet Evol 2013; 20: 413-417.
28. Nakano T, Okano H, Kobayashi M, et al., Molecular epidemiology and genetic history of European-type genotype 3 hepatitis E virus indigenized in the central region of Japan. Infect Genet Evol 2012; 12: 1524-1534.
29. Nakano T, Takahashi K, Pybus OG, et al., New findings regarding the epidemic history and population dynamics of Japan-indigenous genotype 3 hepatitis E virus inferred by molecular evolution. Liver Int 2012; 32: 675-688.
30. Takahashi K, Kitajima N, Abe N, Mishiro S,. Complete or near-complete nucleotide sequences of hepatitis E virus genome recovered from a wild boar, a deer, and four patients who ate the deer. Virology 2004; 330: 501-505.
31. Mansuy JM, Huynh A, Abravanel F, et al., Molecular evidence of patient-to-patient transmission of hepatitis E virus in a hematology ward. Clin Infect Dis 2009; 48: 373-374.
32. Ollier L, Tieulie N, Sanderson F, et al., Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009; 150: 430-431.
33. Peron JM, Mansuy JM, Recher C, et al., Prolonged hepatitis E in an immunocompromised patient. J Gastroenterol Hepatol 2006; 21: 1223-1224.
34. Colson P, Kaba M, Moreau J, Brouqui P,. Hepatitis E in an HIV-infected patient. J Clin Microbiol 2009; 45: 269-271.
35. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S,. Persistent carriage of hepatitis E virus in patients with HIV infection. New Engl J Med 2009; 361: 1025-1027.
36. Eberle J, Gürtler L,. HIV types, groups, subtypes and recombinant forms: errors in replication, selection pressure and quasispecies. Intervirology 2012; 55: 79-83.
37. Oliveira-Filho EF, König M, Thiel HJ,. Genetic variability of HEV isolates: inconsistencies of current classification. Vet Microbiol 2013; 165: 148-154.
38. Baylis SA, Hanschmann KM, Blümel J, Nübling CM,. HEV Collaborative Study Group. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011; 49: 1234-1239.
39. Ward P, Poitras E, Leblanc D, et al., Comparative analysis of different TaqMan real-time RT-PCR assays for the detection of swine Hepatitis E virus and integration of Feline calicivirus as internal control. J Appl Microbiol 2009; 106: 1360-1369.
40. Hamid SS, Jafri SM, Khan H, et al., Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis? J Hepatol 1996; 25: 20-27.
41. Kumar RM, Uduman S, Rana S, et al., Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol 2001; 100: 9-15.
42. Bose PD, Das BC, Hazam RK, et al., Evidence of extrahepatic replication of hepatitis E virus in human placenta. J Gen Virol 2014; 95: 1266-1271.
43. Singh S, Mohanty A, Joshi YK, et al., Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr 2003; 70: 37-39.
44. Labrique AB, Sikder SS, Krain LJ, et al., Hepatitis E, A vaccine-preventable cause of maternal deaths. Emerg Infect Dis 2012; 18: 1401-1404.
45. Cheung MC, Maguire J, Carey I, Wendon J, Agarwal K,. Review of the neurological manifestations of hepatitis E infection. Ann Hepatol 2012; 11: 618-622.
46. Kamar N, Bendall RP, Peron JM, et al., Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011; 17: 173-179.
47. Dieckhoff B, Kessler B, Jobst D, et al., Distribution and expression of porcine endogenous retroviruses in multi-transgenic pigs generated for xenotransplantation. Xenotransplantation 2009; 6: 64-73.
48. Wynyard S, Nathu D, Garkavenko O, Denner J, Elliott R,. Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand. Xenotransplantation 2014; 21: 309-323.
49. Garkavenko O, Muzina M, Muzina Z, et al., Monitoring for potentially xenozoonotic viruses in New Zealand pigs. J Med Virol 2004; 72: 338-344.
50. Garkavenko O, Obriadina A, Meng J, et al., Detection and characterisation of swine hepatitis E virus in New Zealand. J Med Virol 2001; 65: 525-529.
51. Garkavenko O, Dieckhoff B, Wynyard S, et al., Absence of transmission of potentially xenotic viruses in a prospective pig to primate islet xenotransplantation study. J Med Virol 2008; 80: 2046-2052.
52. Bollen P, Ellegaard L,. The Göttingen minipig in pharmacology and toxicology. Pharmacol Toxicol 1997; 80 (Suppl 2): 3-4.
53. Simianer H, Köhn F,. Genetic management of the Göttingen Minipig population. J Pharmacol Toxicol Methods 2010; 62: 221-226.
54. Mc Anutly PA, Hastings KL, Ganderup NC, et al., The Minipig in Biomedical Research. London: CRC Press/Taylor and Francis Group, 2011.
55. Semaan M, Rotem A, Barkai U, Bornstein S, Denner J,. Screening pigs for xenotransplantation: prevalence and expression of porcine endogenous retroviruses in Göttingen minipigs. Xenotransplantation 2013; 20: 148-156.
56. Busby SA, Crossan C, Godwin J, et al., Suggestions for the diagnosis and elimination of hepatitis E virus in pigs used for xenotransplantation. Xenotransplantation 2013; 20: 188-192.
57. Morozov VA, Morozov AV, Rotem A, et al., Extended microbiological characterization of Göttingen minipigs in the context of xenotransplantation: vertical transmission of hepatitis E virus. PLoS ONE, in press.
58. Abrahante JE, Martins K, Papas KK, et al., Microbiological safety of porcine islets: comparison with source pig. Xenotransplantation 2011; 18: 88-93.
59. Sachs DH,. The pig as a potential xenograft donor. Vet Immunol Immunopathol 1994; 43: 185-191.
60. Shimatsu Y, Yamada K, Horii W, et al., Production of cloned NIBS (Nippon Institute for Biological Science) and α-1, 3-galactosyltransferase knockout MGH miniature pigs by somatic cell nuclear transfer using the NIBS breed as surrogates. Xenotransplantation 2013; 20: 157-164.
61. Kamar N, Abravanel F, Lhomme S, et al., Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment. Clin Res Hepatol Gastroenterol 2014; 14: 167-173.
62. Kamar N, Izopet J, Tripon S, et al., Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 2014; 370: 1111-1120.
63. van der Eijk AA, Pas SD, Cornelissen JJ, de Man RA,. Hepatitis E virus infection in hematopoietic stem cell transplant recipients. Curr Opin Infect Dis 2014; 27: 309-315.
64. Abravanel F, Lhomme S, Rostaing L, Kamar N, Izopet J,. Protracted faecal shedding of HEV during ribavirin therapy predicts treatment relapse. Clin Infect Dis 2014; 60: 96-99.
65. Pischke S, Hardtke S, Bode U, et al., Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int 2013; 33: 722-726.
66. Feld JJ, Hoofnagle JH,. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 2005; 436: 967-972.
67. Kamar N, Rostaing L, Abravanel F, et al., Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 2010; 139: 1612-1618.
68. Mallet V, Nicand E, Sultanik P, et al., Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010; 153: 85-89.
69. Junge N, Pischke S, Baumann U, et al., Results of single-center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin. Pediatr Transplant 2013; 17: 343-347.
70. Gerolami R, Borentain P, Raissouni F, et al., Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011; 52: 60-62.
71. Goris N, Vandenbussche F, De Clercq K,. Potential of antiviral therapy and prophylaxis for controlling RNA viral infections of livestock. Antiviral Res 2008; 78: 170-178.
72. Kim Y, Lee C,. Ribavirin efficiently suppresses porcine nidovirus replication. Virus Res 2013; 171: 44-53.
73. Zhu FC, Zhang J, Zhang XF, et al., Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376: 895-902.
74. Wu T, Li SW, Zhang J, et al., Hepatitis E vaccine development: a 14 year odyssey. Hum Vaccin Immunother 2012; 8: 823-827.
75. Shrestha MP, Scott RM, Joshi DM, et al., Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356: 895-903.
76. Deshmukh TM, Lole KS, Tripathy AS, Arankalle VA,. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice. Vaccine 2007; 25: 4350-4360.
77. Kamili S,. Toward the development of a hepatitis E vaccine. Virus Res 2011; 161: 93-100.
78. Cheng X, Wang S, Dai X, et al., Rabbit as a novel animal model for hepatitis E virus infection and vaccine evaluation. PLoS ONE 2012; 7: e51616.
79. Sanford BJ, Opriessnig T, Kenney SP, et al., Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs. Vaccine 2012; 30: 6249-6255.
80. Kamar N, Dalton HR, Abravanel F, Izopet J,. Hepatitis E virus infection. Clin Microbiol Rev 2014; 27: 116-138.